Showing results (51-60 of 556) with videos related to
Sort By:
Pageof 56
Expert Opinion on Therapeutic Targets|January 31, 2003
Cyclin-dependent protein kinases as therapeutic drug targets for antimalarial drug developmentNorman C Waters, Jeanne A GeyerPsychopharmacology|January 1, 1995
8-OH-DPAT disruption of prepulse inhibition in rats: reversal with (+)WAY 100,135 and localization of site of actionT A Sipes, M A GeyerPsychopharmacology|January 1, 1993
Quantitative assessment of the microstructure of rat behavior: I, f(d), the extension of the scaling hypothesisM P Paulus, M A GeyerPsychopharmacology|January 1, 1993
Behavioral characterization of alpha-ethyltryptamine, a tryptamine derivative with MDMA-like properties in ratsK M Krebs, M A GeyerPsychopharmacology|January 1, 1991
Parametric determinants in pre-stimulus modification of acoustic startle: interaction with ketamineR S Mansbach, M A GeyerEuropean Journal of Pharmacology|November 8, 1988
Blockade of potentiated startle responding in rats by 5-hydroxytryptamine1A receptor ligandsR S Mansbach, M A GeyerPharmacology, Biochemistry, and Behavior|March 1, 1993
Clozapine and haloperidol in an animal model of sensorimotor gating deficits in schizophreniaN R Swerdlow, M A GeyerBiological Psychiatry|February 6, 2010
Action of modafinil--increased motivation via the dopamine transporter inhibition and D1 receptors?Jared W Young, Mark A GeyerBiochemical Pharmacology|July 17, 2013
Evaluating the role of the alpha-7 nicotinic acetylcholine receptor in the pathophysiology and treatment of schizophreniaJared W Young, Mark A GeyerProgress in Neuro-Psychopharmacology & Biological Psychiatry|January 1, 1985
Effects of DOM and DMT in a proposed animal model of hallucinogenic activityL M Adams, M A GeyerPageof 56